BPC-157 (5mg / 10mg) Research Peptide: A Stable Pentadecapeptide for Angiogenesis, GI & Musculoskeletal Studies

If your research investigates tissue repair, angiogenesis, or the molecular mechanisms of gastrointestinal protection and musculoskeletal healing, BPC-157 (5mg / 10mg) research peptide — also known as Body Protection Compound-157 — offers a precisely defined synthetic tool. This stable gastric pentadecapeptide was first described in 1993 in the Journal of Physiology, Paris as a naturally occurring peptide in gastric juice with cytoprotective properties. BPC-157 has since been the subject of hundreds of preclinical studies exploring its ability to promote healing across multiple tissue types.

What distinguishes BPC-157 is its remarkable stability and pleiotropic activity: it is native and stable in human gastric juice for more than 24 hours, enhances growth hormone receptor expression, and modulates several pathways involved in cell growth and angiogenesis while reducing inflammatory cytokines. This makes BPC-157 (5mg / 10mg) research peptide a valuable tool for laboratories investigating wound healing, gastrointestinal protection, musculoskeletal repair, and angiogenesis.

At Wuhan Top Miracle Peptides, we supply high‑purity BPC-157 (5mg / 10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into tissue repair, angiogenesis, and cytoprotection begin with uncompromising quality.

What Is BPC-157 and How Does It Work?

To fully appreciate the research potential of BPC-157 (5mg / 10mg) research peptide, it is essential to understand its biochemical identity, its role as a stable gastric pentadecapeptide, and the mechanisms by which it exerts its pleiotropic effects.

The Stable Gastric Pentadecapeptide

BPC-157 is a synthetic peptide consisting of 15 amino acids, derived from a naturally occurring peptide found in human gastric juice. Its sequence is Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val, with a molecular weight of approximately 1499.7 g/mol. It has a CAS number of 137525-51-0. The peptide is notable for its stability in gastric juice, where it remains intact for more than 24 hours. This stability is a key feature that distinguishes it from many other research peptides and contributes to its pleiotropic activity.

Mechanism of Action: Cytoprotection, Angiogenesis and Organoprotection

The biological activity of BPC-157 (5mg / 10mg) research peptide is mediated through several intersecting mechanisms, rooted in the concept of cytoprotection — the innate ability of cells to protect themselves against injury:

Cytoprotection and Gastrointestinal Protection

BPC-157 was first described as a cytoprotective agent that protects stomach cells and maintains gastric integrity against various noxious agents. It promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, including healing GI ulcers, anastomotic sites, and various GI fistulas, as well as in models of inflammatory bowel disease. BPC-157 has demonstrated beneficial effects in models of ulcerative colitis, with no side effects reported in phase II trials.

Angiogenesis via VEGFR2‑Akt‑eNOS Signalling

BPC-157 promotes angiogenesis primarily through the activation of the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) signalling pathway. This activation leads to a downstream cascade involving Akt and endothelial nitric oxide synthase (eNOS), ultimately promoting endothelial cell proliferation, migration, and survival. Increases in VEGF, CD34, and FVIII have been reported in muscle and tendon models, confirming that BPC-157 stimulates angiogenesis.

Modulation of the NO‑System and Free Radical Counteraction

BPC-157 exerts a distinctive effect on nitric oxide (NO) levels — capable of both increasing and decreasing NO as needed — always combined with counteraction of free radical formation. This dual ability to modulate NO while preventing oxidative damage is central to its tissue-protective profile. BPC-157 controls angiogenesis and the NO‑system’s healing functions while counteracting the pathological presentation of neurodegenerative diseases in animal models.

Inhibition of Inflammatory Cytokines and Enhancement of Growth Hormone Receptor Expression

BPC-157 enhances growth hormone receptor expression and reduces inflammatory cytokines. In preclinical models, it has demonstrated improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries.

Organoprotection: Translating Cytoprotection to Other Organs

The cytoprotective effects observed in the gastrointestinal tract can be translated to other tissues through organoprotection. BPC‑157 therapy effectively combines various tissue healing and lesions counteraction across multiple organ systems.

Key Research Applications for BPC-157 (5mg / 10mg)

BPC-157 (5mg / 10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Gastrointestinal & Mucosal Research

As a peptide that promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, BPC‑157 is a valuable tool for studying GI protection and repair. Research applications include:

• GI Ulcer Healing: Investigating BPC‑157’s ability to heal gastric and intestinal ulcers.

• Inflammatory Bowel Disease: Studying BPC‑157’s effects in models of IBD.

• NSAID‑Induced Injury: Exploring the peptide’s protective effects against nonsteroidal anti‑inflammatory drug‑induced injury.

• Anastomotic Healing: Investigating BPC‑157’s potential to promote healing at surgical anastomotic sites.

• GI Fistula Repair: Studying the peptide’s ability to promote closure of various GI fistulas.

2. Musculoskeletal & Orthopaedic Research

BPC‑157 has been extensively studied for its effects on musculoskeletal tissues. Research has demonstrated improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries in preclinical models. Research applications include:

• Tendon Healing: Investigating BPC‑157’s ability to improve biomechanical properties in tendon models, with significant improvements observed by days 14‑21.

• Ligament Repair: Studying the peptide’s effects on ligament healing.

• Muscle Injury: Exploring BPC‑157’s potential to accelerate muscle repair.

• Bone Fracture Healing: Investigating the peptide’s role in bone healing.

• Counteraction of Corticosteroid‑Induced Impairment: BPC‑157 may counteract the healing limitations and tissue impairment associated with corticosteroid treatment.

3. Angiogenesis & Vascular Research

As a promoter of angiogenesis via the VEGFR2‑Akt‑eNOS pathway, BPC‑157 is a valuable tool for studying blood vessel formation and vascular integrity. Research applications include:

• Angiogenesis Signalling: Investigating the molecular pathways involved in BPC‑157‑induced angiogenesis.

• Vascular Integrity: Exploring the peptide’s role in supporting vascular integrity.

• Corneal Research: BPC‑157 resolves cornea transparency maintenance and cornea healing “angiogenic privilege” without producing corneal neovascularization.

4. Neuroprotection & Neurodegenerative Research

BPC‑157 has demonstrated neuroprotective effects in preclinical models. Research applications include:

• Neurodegenerative Disease Models: BPC‑157 counteracts Parkinson’s disease‑like and Alzheimer’s disease‑like disturbances in animal models.

• Neuroprotection: Investigating the peptide’s ability to protect neural tissue.

• Brain‑Gut Axis: Exploring BPC‑157’s role in brain‑gut and gut‑brain functioning.

5. Cardiovascular Research

BPC‑157 has been investigated for its effects on the cardiovascular system. Research applications include:

• Myocardial Infarction: Studying the peptide’s effects on heart disturbances and myocardial infarction.

• Heart Failure: Investigating BPC‑157’s potential in models of heart failure.

• Thrombosis and Arrhythmias: Exploring the peptide’s effects on thrombosis and arrhythmias.

Chemical & Physical Specifications for BPC-157 (5mg / 10mg)

Accurate characterisation of BPC-157 (5mg / 10mg) research peptide is essential for reproducible experimental design.

Note: The 5 mg and 10 mg masses refer to the weight of the peptide in its lyophilised form. BPC‑157 is typically supplied as a TFA or acetate salt, which enhances aqueous solubility. The peptide is notable for its stability — it is native and stable in human gastric juice for more than 24 hours.

Reconstitution & Handling Protocol for BPC-157 (5mg / 10mg)

Proper reconstitution of BPC-157 (5mg / 10mg) research peptide is critical for maintaining its structural integrity and biological activity. The peptide has a reported half‑life of less than 30 minutes, so careful handling is essential.

Step 1 – Preparation

• Bring the sealed BPC‑157 vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the BPC-157 (5mg / 10mg) vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 5 mg or 10 mg per 1 mL of diluent, yielding a 5‑10 mg/mL stock solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted BPC‑157 into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table

Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.

Storage & Stability Guidelines for BPC-157 (5mg / 10mg)

Why Choose Wuhan Top Miracle Peptides for BPC-157 (5mg / 10mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply BPC-157 (5mg / 10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: BPC-157 (5mg / 10mg) Research Peptide

What is BPC‑157 research peptide?
BPC‑157 (Body Protection Compound‑157) is a synthetic pentadecapeptide derived from a naturally occurring peptide found in human gastric juice. It is a stable gastric peptide that promotes mucosal integrity, angiogenesis, and tissue healing across multiple organ systems.

What is the sequence and molecular weight of BPC‑157?
The sequence is Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val (GEPPPGKPADDAGLV). Its molecular weight is approximately 1499.7 g/mol.

What are the primary research applications for BPC‑157?
BPC‑157 is used in gastrointestinal and mucosal research (GI ulcer healing, IBD, NSAID‑induced injury), musculoskeletal and orthopaedic research (tendon, ligament, muscle, bone healing), angiogenesis and vascular research, neuroprotection and neurodegenerative research, and cardiovascular research.

What is the mechanism of action of BPC‑157?
BPC‑157 acts through multiple mechanisms: it promotes angiogenesis via VEGFR2‑Akt‑eNOS signalling, modulates the NO‑system while counteracting free radicals, reduces inflammatory cytokines, enhances growth hormone receptor expression, and exerts cytoprotective and organoprotective effects.

What purity does your BPC‑157 (5mg / 10mg) meet?
Our BPC‑157 is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute BPC‑157?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.

How should I store reconstituted BPC‑157?
Reconstituted BPC‑157 should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

Is BPC‑157 stable in solution?
BPC‑157 is notable for its stability — it is native and stable in human gastric juice for more than 24 hours. However, like all peptides, it should be handled with aseptic technique and stored appropriately.

Is BPC‑157 research peptide legal to purchase in the UK?
Yes. BPC‑157 is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. It is not FDA‑approved and is banned in professional sports.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale BPC-157 (5mg / 10mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger BPC-157 5mg or 10mg enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, product identity, vial strength, and buyer verification requirements.

Where to Source BPC-157 (5mg / 10mg) in the UK

If you are searching for where to source BPC-157 (5mg / 10mg) in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the BPC-157 5mg and 10mg product details.
2. Check the current label and batch information.
3. Confirm whether the batch is listed as BPC-157 or another verified identity.
4. Confirm whether you need the 5mg or 10mg vial option.
5. Ask about COA and purity-related documentation.
6. Confirm the sequence and salt form where required.
7. Confirm storage information and shipping country.
8. Discuss wholesale quantity requirements.
9. Complete buyer verification where required.
10. Place a professional enquiry with support from our team.

BPC-157 (5mg / 10mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
TB-500 Product Page
BPC-157 & TB-500 Blend Page
Scientific or compound reference source
PubChem / compound database reference
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

BPC-157 (5mg / 10mg)

From its discovery as a stable gastric pentadecapeptide to its well‑characterised role in promoting angiogenesis, cytoprotection, and tissue healing across multiple organ systems, BPC-157 (5mg / 10mg) research peptide provides a precisely defined and extensively validated platform for advanced biomedical research. Its ability to activate VEGFR2‑Akt‑eNOS signalling, modulate the NO‑system, reduce inflammatory cytokines, and enhance growth hormone receptor expression — supported by decades of peer‑reviewed research published in PubMed, the Journal of Physiology, Paris, Inflammopharmacology, and other authoritative journals — makes it a valuable addition to any laboratory investigating gastrointestinal protection, musculoskeletal repair, angiogenesis, or neuroprotection.

By choosing high‑purity, lab‑verified BPC-157 (5mg / 10mg) research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with BPC‑157 (5mg / 10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade BPC‑157 delivered directly to your facility in the UK, EU, or USA.